RECENT PUBLICATIONS

Dietz, A.B., Bulur, P.A., Erickson, M.R., Wettstein, P.J., Litzow, M.R., Wyatt, W.A., Dewald, G.W., Tefferi, A., Pankratz, V.S. and Vuk-Pavlovic, S. (2000). Optimizing preparation of normal dendritic cells and bcr-abl positive mature dendritic cells derived from immunomagnetically purified CD14 positive cells. J. Hematother. Stem Cell Res. 9, 95-101.

Burch, P.A., Breen, J.K., Buckner, J.C., Gastineau, D.A., Kaur, J.A., Laus, R.L., Padley, D.J. Peshwa, M.V., Pitot, H.C., Richardson, R.L., Smits, B.J., Sopapan, P., Strang, G., Valone, F.H. and Vuk-Pavlovic, S. (2000). Priming tissue-specific cellular immunity in a phase I trial of autlogous dendritic cells for prostate cancer. Clin. Cancer Res. 6, 2175-2182.

Bajzer, Z., Dietz, A. B. and Vuk-Pavlovic, S. (2000). New dimensions in Gompertzian growth. J. Theor. Med. 2, 307-315.

Matasic, R., Dietz, A.B. and Vuk-Pavlovic, S. (2000). Cyclooxygenase independent inhibition of dendritic cell maturation by aspirin. Immunology 101, 53-60.

Dietz, A.B., Bulur, P.A., Knutson, G.J., Matasic, R. and Vuk-Pavlovic, S. (2000). Maturation of human monocyte-derived dendritic cells stuied by microarray hybridization. Biochem. Biophys. Res. Commun. 275, 731-738.

Dietz, A.B., Bulur, P.A., Brown, C.A., Pankratz, V.S. and Vuk-Pavlovic, S. (2001). Maturation of dendritic cells infected by recombinant adenovirus can be delayed without impact on transgene expression. Gene Ther. 8, 419-423.

Dietz, A.B., Litzow, M.R., Bulur, P.A. and Vuk-Pavlovic, S. (2001). Transgenic interleukin 2 secreted by CML dendritic cells stimulates autlogous T_H1 T cells. Cytotherapy 3, 97-105.

Dietz, A.B., Litzow, M.R., Gastineau, D.A. and Vuk-Pavlovic, S. (in press). Engineering dendritic cells grafts for clinical trials in cellular immunotherapy of cancer: the example of chronic myelogenous leukemia. Croat. Med. J. 42, 427-434.

Padley, D.J., Dietz, A.B., Gastineau, D.A. and Vuk-Pavlovic, S. (2001). Mature myeloid dendritic cells for clinical use prepared from CD14-positive cells isolated by immunomagnetic adsorption. J. Hematother. Stem Cell Res. 10, 427-429.

Matasic, R., Dietz, A.B. and Vuk-Pavlovic, S. (2001). Maturation of human dendritic cells as sulfasalazine target. Croat. Med. J. 42, 440-445.

Fisher, P.J. Springett, M.J., Dietz, A.B., Bulur, P.A. and Vuk-Pavlovic, S. (2002). Immunomagnetic separation reagents as markers in electron microscopy. J. Immunol. Methods 262(1-2):95-101.

Dietz, A.B., Litzow, M.R., Bulur, P.A. and Vuk-Pavlovic, S. (2002). Transgenic interleukin 2 secreted by CML dendritic cells stimulates autologous T(H)1 T cells. Cytotherapy 3(2), 97-105.

Antica, M., Kusic, B., Hranilovic, D., Dietz, A.B. and Vuk-Pavlovic, S. (2002). Cloning the cDNA for murine U2 snRNP-AÕ gene and its differential expression in lymphocyte development. Immunol. Lett. 82(3), 217-223.

Burch, P.A., Croghan, G.A., Gastineau, D.A., Jones, L.A., Kaur, J.S., Kylstra, J.W., Richardson, R.L., Valone, F.H., Vuk-Pavlovic, S.: Immunotherapy (APC8015, Provenge ï) targeting prostatic acid phosphatase can induce durable remission of metastatic androgen-independent prostate cancer: A phase 2 trial. The Prostate, in press, 2004.

Bajzer, Z., Vuk-Pavlovic, S.: Cell interactions as positive regulatory feedbacks. Submitted for publication.

Decker, G.A., Dietz, A.B., Gores, G.J., Nyberg, S.L., Vuk-Pavlovic, S.: Serum levels of vascular endothelial growth factor and stem cell factor in the course of liver regeneration in humans. Submitted for publication.

Dietz, A.B., Bulur, P.A., Knutson, G.J., Souan, L., Litzow, M.R., Vuk-Pavlovic, S.: Imatinib mesylate inhibits proliferation of T cells in vitro and delayed-type hypersensitivity in vivo. Submitted for publication.

Dietz, A.B., Fisher, P.J., Bulur, P.A., Knutson, G.J., Prendergast, F.G., Vuk-Pavlovic, S.: Morphology of dendritic cell-T cell interaction site. Submitted for publication.